1. Home
  2. MLAB vs BCYC Comparison

MLAB vs BCYC Comparison

Compare MLAB & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$89.26

Market Cap

447.4M

Sector

Industrials

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$6.51

Market Cap

476.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLAB
BCYC
Founded
1982
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.4M
476.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MLAB
BCYC
Price
$89.26
$6.51
Analyst Decision
Hold
Buy
Analyst Count
1
11
Target Price
$83.00
$18.73
AVG Volume (30 Days)
102.8K
247.3K
Earning Date
02-03-2026
02-24-2026
Dividend Yield
0.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$245,255,000.00
$28,339,000.00
Revenue This Year
$4.96
N/A
Revenue Next Year
$5.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.39
N/A
52 Week Low
$55.45
$6.03
52 Week High
$155.12
$14.95

Technical Indicators

Market Signals
Indicator
MLAB
BCYC
Relative Strength Index (RSI) 65.53 43.09
Support Level $80.00 $6.37
Resistance Level $89.95 $6.88
Average True Range (ATR) 4.23 0.32
MACD 0.40 -0.02
Stochastic Oscillator 88.59 23.63

Price Performance

Historical Comparison
MLAB
BCYC

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: